Wednesday, April 22, 2026

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

Experience the Future: HD Construction Machinery’s Mini Electric Excavator HX19E Takes Center Stage at CONEXPO 2026

HD Construction Equipment showcased its electric excavators at CONEXPO 2026, engaging visitors with an Operator Challenge and demos.

Is South Korea’s Soft Approach to North Korea Backfiring? Insights from Kim Jong Un’s Latest Critique

North Korea's Kim Jong Un mocks South Korea's conciliatory policies, prompting criticism from the People Power Party over ineffective dialogue.

Tag: PARP inhibitors

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.